Single-Layer vs. Dual-Layer Amniotic Grafts: Composition, Handling, and Outcomes

Amniotic membrane products come in three broad configurations: single-layer amnion, single-layer chorion, and dual-layer amnion/chorion (dHACM being the most common dehydrated form). They differ in tissue thickness, growth-factor profile in vitro, handling characteristics, and — in some settings — clinical performance.

Composition

• Amnion (single layer). The inner fetal-facing layer. Thin, translucent, easier to conform to complex wound geometry. Contains a range of growth factors and cytokines but at generally lower absolute content than a dual-layer product because of the smaller tissue mass.
• Chorion (single layer). The outer maternal-facing layer. Thicker, denser extracellular matrix. Reported in vitro to carry higher concentrations of PDGF-BB, TGF-β, and bFGF than amnion alone ^[1].
• Dual-layer amnion/chorion (dHACM). Both layers preserved and processed together. Combines the conformability of amnion with the growth-factor content of chorion.

Handling differences

• Single-layer amnion is thin and drapes into tunneled or contoured wounds well but tears more easily during rehydration.
• Chorion-alone products are thicker and more robust but less conformable.
• Dual-layer dHACM sits in between: robust enough to handle, thin enough to conform.

Clinical evidence

The strongest published DFU RCTs have used dual-layer dHACM ^[2][3]. Single-layer amnion has strong published evidence in ocular surface applications; skin-wound single-layer evidence is thinner. Chorion-only skin-wound trials exist but are smaller. Head-to-head, blinded RCTs of single-layer vs. dual-layer at the same anatomic site are limited ^[4].

Practical implication: for chronic lower-extremity wounds where you want an evidence-supported default, dual-layer dHACM is the most defensible choice. For thin, high-conformability applications (e.g., tunneled tracts, complex geometries), single-layer amnion has practical handling advantages.

Cost and packaging

Dual-layer products typically carry higher per-cm² pricing than single-layer amnion alone. In a formulary consolidation, most centers keep a dual-layer product as the primary SKU and one single-layer amnion for conformability cases.

FAQ

Is dual-layer always better than single-layer?

No. Dual-layer has broader published DFU evidence, but single-layer amnion has real advantages for conformability in complex wound geometries. The right choice depends on the wound.

Do the two products bill under the same Q-code?

Not necessarily — every processed amniotic product has its own assigned HCPCS Q-code (or is billed under a general skin-substitute code). Always verify the current HCPCS assignment in the CMS file ^[5].

How much difference does growth-factor content actually make clinically?

In-vitro growth-factor differences are documented ^[1], but the clinical benefit is mediated by wound bed preparation, offloading, and application frequency. Growth-factor content alone should not drive product selection.

Which is easier to store?

Both single-layer and dual-layer dehydrated products are ambient shelf-stable, typically 3–5 years. Cryopreserved variants require ≤ −65 °C storage.

Are there any wounds where single-layer amnion is preferred?

Complex tunneling wounds, small delicate defects (e.g., digits), and ocular surface applications frequently favor single-layer amnion for handling and conformability reasons.